Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Nusantara Sawit Sejahtera Tbk. (NSSS) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Nusantara Sawit Sejahtera Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Nusantara Sawit Sejahtera Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Nusantara Sawit Sejahtera Tbk. trades at Rp800 (market cap 18.45T, 10.52M 24h volume). The key difference: Nusantara Sawit Sejahtera Tbk. is far larger — about 59.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Nusantara Sawit Sejahtera Tbk. is more actively traded (10.52M versus 963.6K). Which is the better fit depends on your goals.

DGNSNSSS
Market Cap
310.75B18.45T
Volume
963.6K10.52M
Lot
9.64K105.24K
Turnover
217.67M8.34B
Average Price
225.89792.82
Value
217.67M8.34B
Indicative Equilibrium Price
226800
Indicative Equilibrium Volume
1K434

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
NSSS
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Nusantara Sawit Sejahtera Tbk.

PT Nusantara Sawit Sejahtera Tbk (the Company) was established based on the Notarial DeedNo. 01 and No. 14 of Engawati Gazali, S.H., dated April 1, 2009 and June 12, 2009, respectively, and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia in its Decision Letter No. AHU-28662.AH.01.01 dated June 26, 2009. The Company started its commercialoperations in 2020.

Read more on NSSS